Danaher Corporation vs Medpace
Danaher Corporation (DHR) and Medpace (MEDP) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $155B
- Last close
- $220.36
- 12 months
- −0.8%
- Market value
- $17.1B
- Last close
- $610.54
- 12 months
- +4.2%
At a glance
- The biggest part of Danaher Corporation's revenue is Diagnostics (40%); at Medpace it is Oncology (30%).
- By market value, Danaher Corporation ($155.0B) is about 9.1 times Medpace ($17.1B).
- Over the last 12 months Danaher Corporation's share price moved −0.8% and Medpace's +4.2%; against the S&P 500 that is −6.5 points and −1.6 points.
- In their last fiscal years Danaher Corporation kept 14.7% of revenue as net income and Medpace 17.8%.
- In the last 90 days insiders reported 0 open-market purchases at Danaher Corporation and 0 at Medpace; members of Congress disclosed 2 trades in Danaher Corporation and 0 in Medpace.
- Next results: Danaher Corporation Jan 26, 2027, Medpace Feb 8, 2027.
How each one makes money: Danaher Corporation revenue · Medpace revenue
Share prices on one chart
Danaher Corporation and Medpace, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Danaher Corporation DHRNYSE · Life Sciences Tools & Services | Medpace MEDPNASDAQ · Life Sciences Tools & Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $155B | $17.1B |
| Revenue, last fiscal year | $24.6B | $2.53B |
| Net income, last fiscal year | $3.61B | $451M |
| Net marginNet income as a share of revenue | 14.7% | 17.8% |
| Free cash flow | $5.26B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Danaher Corporation against
Common questions
How is Danaher Corporation different from Medpace?
Danaher Corporation (DHR) is in Life Sciences Tools & Services on NYSE, with $24.6B of revenue in its last fiscal year and a net margin of 14.7%. Medpace (MEDP) is in Life Sciences Tools & Services on NASDAQ, with $2.53B of revenue in its last fiscal year and a net margin of 17.8%. The biggest part of Danaher Corporation's revenue is Diagnostics (40%); at Medpace it is Oncology (30%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Danaher Corporation and Medpace compare in size?
Danaher Corporation has the larger market value: Danaher Corporation $155B and Medpace $17.1B, at the last close.
Whose share price rose more over the last 12 months, DHR or MEDP?
Over the last 12 months Danaher Corporation moved −0.8% and Medpace +4.2%. Past price moves say nothing about the future.
Which has had more insider buying, Danaher Corporation or Medpace?
Since 2006, Medpace insiders reported 40 open-market purchases against 26 for Danaher Corporation. These are counts of what was filed, not a view on either stock.
Do members of Congress trade DHR or MEDP?
In the last 12 months, members of Congress disclosed 6 trades in Danaher Corporation (DHR) and 6 in Medpace (MEDP).
When did insiders last buy DHR and MEDP?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Danaher Corporation pageMedpace pageRare insider trades this weekAll comparisons
https://oqro.io/compare/dhr-vs-medp







